Insulin

Insulin pricing is yet another case where state lawmakers can choose whether or not to save the lives of their constituents.

A wide swath of Americans report using less insulin than they're prescribed because of cost concerns.

The reality of a life with diabetes is much more than a matter of malfunctioning bodily organs.

Researchers at the University of Toronto filed the first patent for insulin therapy 92 years ago. Today, there's still no lower-cost generic.